Abstract
‘. . . .the leukemic stem line is a small minority within the total cell mass; . . . . when the leukemic stem line is not exceeding the normal stem cell numbers, its proliferation may still be under partial control. . . .’ LG Lajtha, Blood Cells 1981; 7 : 45–62
We performed cytogenetic analysis on fresh bone marrow cells and on progenitor cell colonies in a patient who relapsed after allogeneic BMT for CML and was subsequently treated with donor lymphocyte infusions (DLI). Two Philadelphia-positive clones were identified at relapse. One clone displayed an additional chromosomal abnormality most likely induced by radio-chemotherapy and therefore arising in a single cell. This cell displays the characteristics of a stem cell, since it was able to support 20% of Ph-positive hemopoiesis for 5 months. If the progeny of a single Ph-positive stem cell account for 20% of hemopoiesis, a very low number of leukemic stem cells may sustain relapse after allogeneic BMT. This is in keeping with two observations: (1) at relapse, long-term culture initiating cells (LTC-IC) were all donor-derived and Ph-negative; (2) on average, the pace of the disease is very slow after relapse following allogeneic-BMT. Therefore, we hypothesize that a small number of leukemic stem cells may be involved in the initial events of relapse following BMT for CML.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frassoni, F., Podestà, M., Piaggio, G. et al. Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic ‘stem cells’: a hypothesis. Bone Marrow Transplant 24, 689–691 (1999). https://doi.org/10.1038/sj.bmt.1701951
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701951
Keywords
This article is cited by
-
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions
Bone Marrow Transplantation (2003)